Wong Ryan Ho-Yan 4

What Happened
Ryan Ho-Yan Wong, Chief Financial Officer of Sarepta Therapeutics (SRPT), had a total of 275 shares withheld by the company to satisfy tax-withholding obligations tied to vested restricted stock units. The withholding occurred on March 9, 2026, in two lots: 162 shares at $16.95 each (reported value $2,746) and 113 shares at $16.95 each (reported value $1,915), for a combined reported value of $4,661. This is a routine tax-withholding disposition (transaction code F), not an open-market sale.

Key Details

• Transaction date: 2026-03-09; Price reported: $16.95 per share
• Shares withheld/disposed: 162 shares ($2,746) and 113 shares ($1,915); total 275 shares ($4,661)
• Footnotes: F1 = withholding for RSUs granted Mar 7, 2022; F2 = withholding for RSUs granted Mar 6, 2023
• Shares owned after transaction: not specified in the excerpt provided (see the full Form 4 for post-transaction ownership)
• Filing timeliness: Report period 2026-03-09, filing date 2026-03-11 — appears timely (no late filing indicated)

Context
Code F transactions are share withholdings used to satisfy tax obligations when RSUs vest; they are administrative and common after vesting and generally do not signal a directional view of the stock. For more detail on total beneficial ownership or the underlying RSU grants, check the full Form 4 (accession 0001193125-26-102710).